Related Experiment Video
Updated: Jan 10, 2026

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
Network-Level Organization of Systemic Inflammation Reflects Early Alzheimer's-Like Behavioral Changes
Macy A Seijo1, Anisha Banerjee1, Caesar M Hernandez1
1University of Alabama at Birmingham.
None:
Systemic immune alterations are increasingly recognized as features of Alzheimer's disease (AD), yet their network-level organization in preclinical models is poorly understood. We profiled 66 circulating cytokines and growth factors in young adult TgF344-AD and wild-type rats, reduced the data into five inflammatory profiles via principal component analysis, and mapped these profiles onto protein-protein interaction networks. Multivariate analyses revealed genotype- and sex-dependent network organization, with distinct modules enriched for extracellular matrix-linked interleukin signaling or systemic pro-inflammatory cytokine receptor signaling. Regression analyses controlling for genotype and sex linked these networks to specific behavioral domains: extracellular matrix-associated interleukins predicted altered intertemporal choice, whereas pro-inflammatory cytokine receptor signaling correlated with reduced motivation. These findings provide evidence consistent with systemic inflammatory network remodeling at prodromal stages in a preclinical AD model of AD-like pathology and outline a mechanistically interpretable analytical framework with clear translational potential for integrating peripheral immune signatures with behavioral outcomes across species.
More Related Videos
08:01Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits
Published on: March 16, 2016
06:46Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
Published on: August 4, 2018
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Neural Regulation